Market Place
Sourcing Support
Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
BUSINESSWIRE
Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
24 Jul 2024 //
BIOSPACE
Amylyx Acquires Phase 3 GLP-1 Antagonist With FDA Breakthrough Status
10 Jul 2024 //
BUSINESSWIRE
Amylyx To Host Call On Avexitide Acquisition
09 Jul 2024 //
BUSINESSWIRE
Amylyx to buy bankrupt Eiger`s experimental drug to treat low blood sugar
22 Jun 2024 //
REUTERS
Eiger BioPharma Announces New Data Supporting Broader Potential of Avexitide
13 Jun 2022 //
PRNEWSWIRE
Eiger Announces Publication of Phase 2 PREVENT Study Results of Avexitide
23 Feb 2021 //
PRNEWSWIRE
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide
19 Jun 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.